NeoGenomics
235 hedge funds and large institutions have $1.65B invested in NeoGenomics in 2019 Q1 according to their latest regulatory filings, with 71 funds opening new positions, 74 increasing their positions, 72 reducing their positions, and 44 closing their positions.
1,590% more call options, than puts
Call options by funds: $12.6M | Put options by funds: $747K
78% more capital invested
Capital invested by funds: $923M → $1.65B (+$724M)
61% more first-time investments, than exits
New positions opened: 71 | Existing positions closed: 44
50% more funds holding in top 10
Funds holding in top 10: 6 → 9 (+3)
12% more funds holding
Funds holding: 210 → 235 (+25)
6.78% more ownership
Funds ownership: 78.36% → 85.15% (+6.8%)
3% more repeat investments, than reductions
Existing positions increased: 74 | Existing positions reduced: 72
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$144M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$29.2M |
| 3 |
Invesco
Atlanta,
Georgia
|
+$27.1M |
| 4 |
State Street
Boston,
Massachusetts
|
+$19.1M |
| 5 |
Bank of New York Mellon
New York
|
+$18.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ECM
Element Capital Management
New York
|
-$32.8M |
| 2 |
LCM
Laurion Capital Management
New York
|
-$15.9M |
| 3 |
Janus Henderson Group
London,
|
-$13.7M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$12.8M |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$11.2M |
NEO Hedge Fund Activity: Q1 2019 in Review
235 of the 4,633 institutional investors tracked by Wall St. Rank reported a position in NeoGenomics (NEO) for Q1 2019, worth a combined $1.65B — up 78% from $923M a quarter earlier.
Buyers outnumbered sellers: 71 funds opened new NEO positions and 44 closed out — a net gain of 27 holders — while 74 added to existing stakes and 72 trimmed.
The largest buyer was BlackRock, adding an estimated $144M. The largest seller was Element Capital Management, cutting an estimated $32.8M.
- 235 institutional investors held NeoGenomics (NEO) as of Q1 2019, up from 210 in Q4 2018.
- Funds reported $1.65B of NeoGenomics stock for Q1 2019, up 78% quarter-over-quarter.
- 71 funds opened new NeoGenomics positions in Q1 2019 and 44 closed out, a net change of +27 holders.
- The largest NeoGenomics buyer in Q1 2019 was BlackRock, an estimated $144M added.
- The largest NeoGenomics seller in Q1 2019 was Element Capital Management, an estimated $32.8M sold.
Based on aggregated 13F filings for Q1 2019.